Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8V8K

Crystal Structure of Nanobody NbE

8V8K の概要
エントリーDOI10.2210/pdb8v8k/pdb
分子名称Nanobody NbE (1 entity in total)
機能のキーワードsingle domain antibody, nanobody, vhh, immune system
由来する生物種Lama glama
タンパク質・核酸の鎖数3
化学式量合計40037.31
構造登録者
Koehl, A.,Manglik, A.,Yu, J.,Kumar, A.,Zhang, X.,Martin, C.,Raia, P.,Steyaert, J.,Ballet, S.,Boland, A.,Stoeber, M. (登録日: 2023-12-05, 公開日: 2024-09-11, 最終更新日: 2024-10-23)
主引用文献Yu, J.,Kumar, A.,Zhang, X.,Martin, C.,Van Holsbeeck, K.,Raia, P.,Koehl, A.,Laeremans, T.,Steyaert, J.,Manglik, A.,Ballet, S.,Boland, A.,Stoeber, M.
Structural basis of mu-opioid receptor targeting by a nanobody antagonist.
Nat Commun, 15:8687-8687, 2024
Cited by
PubMed Abstract: The μ-opioid receptor (μOR), a prototypical G protein-coupled receptor (GPCR), is the target of opioid analgesics such as morphine and fentanyl. Due to the severe side effects of current opioid drugs, there is considerable interest in developing novel modulators of μOR function. Most GPCR ligands today are small molecules, however biologics, including antibodies and nanobodies, represent alternative therapeutics with clear advantages such as affinity and target selectivity. Here, we describe the nanobody NbE, which selectively binds to the μOR and acts as an antagonist. We functionally characterize NbE as an extracellular and genetically encoded μOR ligand and uncover the molecular basis for μOR antagonism by determining the cryo-EM structure of the NbE-μOR complex. NbE displays a unique ligand binding mode and achieves μOR selectivity by interactions with the orthosteric pocket and extracellular receptor loops. Based on a β-hairpin loop formed by NbE that deeply protrudes into the μOR, we design linear and cyclic peptide analogs that recapitulate NbE's antagonism. The work illustrates the potential of nanobodies to uniquely engage with GPCRs and describes lower molecular weight μOR ligands that can serve as a basis for therapeutic developments.
PubMed: 39384768
DOI: 10.1038/s41467-024-52947-6
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.85 Å)
構造検証レポート
Validation report summary of 8v8k
検証レポート(詳細版)ダウンロードをダウンロード

252091

件を2026-04-15に公開中

PDB statisticsPDBj update infoContact PDBjnumon